Candriam Equities L Oncology Impact R/ LU1864482861 /
| NAV05/06/2024 | Diferencia+2.1100 | Tipo de beneficio | Enfoque de la inversión | Sociedad de fondos |
|---|---|---|---|---|
| 190.7200USD | +1.12% | paying dividend | Equity Worldwide | Candriam ▶ |
Rendimiento mensual
| ene. | feb. | mar. | abr. | may. | jun. | jul. | ago. | sep. | oct. | nov. | dic. | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | -1.46 | -5.36 | -3.08 | 12.11 | 8.53 | 1.40 | 4.43 | 2.14 | 3.50 | -2.21 | 5.80 | 3.85 | +32.28% |
| 2021 | 0.54 | -4.21 | -0.10 | 2.32 | 0.17 | 3.52 | -0.97 | 5.58 | -3.78 | 3.36 | -6.38 | 3.98 | +3.34% |
| 2022 | -10.50 | -1.76 | 4.64 | -5.86 | -1.34 | 0.04 | 4.36 | -3.15 | -4.72 | 7.03 | 6.07 | -3.45 | -9.76% |
| 2023 | 2.15 | -3.89 | 1.37 | 2.82 | -2.57 | 0.07 | 0.88 | -2.02 | -5.25 | -6.36 | 9.21 | 5.72 | +1.01% |
| 2024 | 1.36 | 4.14 | 1.48 | -3.39 | 2.46 | 2.15 | - | - | - | - | - | - | - |
Meses individuales: Dividendos no considerados
Valores estimados
| Año hasta la fecha | 6 Meses | Promedio móvil | 3 Años | 5 Años | |
|---|---|---|---|---|---|
| Volatilidad | 10.74% | 10.99% | 11.68% | 14.68% | -% |
| Índice de Sharpe | 1.57 | 2.37 | 0.30 | -0.18 | - |
| El mes mejor | +5.72% | +5.72% | +9.21% | +9.21% | +12.11% |
| El mes peor | -3.39% | -3.39% | -6.36% | -10.50% | -10.50% |
| Pérdida máxima | -6.79% | -6.79% | -15.42% | -25.23% | - |
| Rendimiento superior | - | - | - | - | - |
Todas las cotizaciones en USD
Tramos
| Nombre | Tipo de beneficio | Prec. de rescate | Promedio móvil | 3 Años | |
|---|---|---|---|---|---|
| Candriam Equities L Oncology Imp... | reinvestment | 2,393.9099 | +7.72% | +4.62% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,558.2000 | +7.86% | +5.01% | |
| Candriam Equities L Oncology Imp... | reinvestment | 207.0400 | +4.18% | -6.19% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,229.6499 | +4.43% | +15.08% | |
| Candriam Equities L Oncology Imp... | paying dividend | 1,606.3300 | +7.38% | +3.61% | |
| Candriam Equities L Oncology Imp... | reinvestment | 244.6500 | +4.85% | +12.98% | |
| Candriam Equities L Oncology Imp... | paying dividend | 235.4400 | +6.37% | +0.75% | |
| Candriam Equities L Oncology Imp... | paying dividend | 190.7200 | +7.27% | +3.31% | |
| Candriam Equities L Oncology Imp... | paying dividend | 20,641.0000 | +2.52% | +0.59% | |
| Candriam Equities L Oncology Imp... | reinvestment | 157.7300 | +4.31% | +14.69% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,106.0200 | +5.17% | -3.50% | |
| Candriam Equities L Oncology Imp... | reinvestment | 259.3200 | +5.74% | +15.86% | |
| Candriam Equities L Oncology Imp... | reinvestment | 206.4900 | +3.76% | -7.29% | |
| Candriam Equities L Oncology Imp... | reinvestment | 285.9900 | +7.27% | +3.30% | |
| Candriam Equities L Oncology Imp... | reinvestment | 193.4200 | +5.05% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 1,839.3500 | +4.77% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,843.2800 | +6.18% | +3.59% | |
| Candriam Equities L Oncology Imp... | reinvestment | 157.2500 | - | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 270.5100 | +5.19% | +0.71% |
Performance
| Año hasta la fecha | +8.31% | ||
|---|---|---|---|
| 6 Meses | +13.87% | ||
| Promedio móvil | +7.27% | ||
| 3 Años | +3.31% | ||
| 5 Años | - | ||
| 10 Años | - | ||
| Desde el principio | +36.36% | ||
| Año | |||
| 2023 | +1.01% | ||
| 2022 | -9.76% | ||
| 2021 | +3.34% | ||
| 2020 | +32.28% | ||
Dividendos
| 29/04/2024 | 3.64 USD |
| 28/04/2023 | 2.69 USD |
| 28/04/2022 | 3.36 USD |
| 28/04/2021 | 3.25 USD |
